Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.2K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex-Related Differences in the Immune System Drive Differential Responses to Anti-PD-1 Immunotherapy.

Biomolecules·2025
Same author

Modulation of blood pressure by dietary potassium and sodium: sex differences and modeling analysis.

American journal of physiology. Renal physiology·2024
Same author

A modeling analysis of whole body potassium regulation on a high-potassium diet: proximal tubule and tubuloglomerular feedback effects.

American journal of physiology. Regulatory, integrative and comparative physiology·2024
Same author

Computational Multi-Scale Modeling of Drug Delivery into an Anti-Angiogenic Therapy-Treated Tumor.

Cancers·2023
Same author

Effect of pregnancy and hypertension on kidney function in female rats: Modeling and functional implications.

PloS one·2023
Same author

A mathematical model of potassium homeostasis: Effect of feedforward and feedback controls.

PLoS computational biology·2022
Same journal

Mathematical Modeling Shows that Overall Infection Burden is Reduced More by Vaccines that Decrease Spread or Accelerate Recovery than those that Lower Severe Infections or Death.

Bulletin of mathematical biology·2026
Same journal

Effects of Seasonal Births and Predation on Disease Spread.

Bulletin of mathematical biology·2026
Same journal

Identifiability, Sensitivity, and Genetic Algorithms in Bacterial Biofilm Selection Models.

Bulletin of mathematical biology·2026
Same journal

Slow Evolution Towards Generalism in a Model of Variable Dietary Range.

Bulletin of mathematical biology·2026
Same journal

CBINN: Cancer Biology-Informed Neural Network for Unknown Parameter Estimation and Missing Physics Identification.

Bulletin of mathematical biology·2026
Same journal

A Cost-Sensitive Behavioral Modeling Analysis of the Early Identification and Control of Infectious Diseases.

Bulletin of mathematical biology·2026
See all related articles

Related Experiment Video

Updated: Mar 27, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K

Integrating Mechanistic Modeling and Machine Learning to Study CD4+/CD8+ CAR-T Cell Dynamics with Tumor Antigen

Saranya Varakunan1, Melissa Stadt2, Mohammad Kohandel2

  • 1Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario, N2L 3G1, Canada. saranya.varakunan@uwaterloo.ca.

Bulletin of Mathematical Biology
|March 25, 2026
PubMed
Summary
This summary is machine-generated.

This study models CAR T-cell therapy dynamics, revealing CD4+ and CD8+ T-cell interactions are key to treatment success. Mathematical modeling and AI show how T-cell composition impacts patient outcomes in blood cancer therapy.

Keywords:
CAR-T therapyImmunotherapyMachine learningMechanistic modeling

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.7K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.9K

Related Experiment Videos

Last Updated: Mar 27, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

7.9K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

15.7K
Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.9K

Area of Science:

  • Immunology
  • Mathematical Biology
  • Computational Oncology

Background:

  • Chimeric antigen receptor (CAR) T cell therapy shows promise in hematological malignancies but exhibits variable patient responses.
  • The distinct roles of CD4+ helper and CD8+ cytotoxic T cell subsets in CAR T-cell therapy efficacy are not fully elucidated.

Purpose of the Study:

  • To develop an extended mathematical framework modeling CAR T-cell dynamics, explicitly incorporating CD4+ and CD8+ T cell subsets.
  • To investigate the influence of CD4+-mediated interactions on CD8+ T cell functions and overall treatment outcomes.
  • To explore the utility of data-driven methods in complementing mechanistic modeling for predicting patient responses under uncertainty.

Main Methods:

  • Developed a system of differential equations extending a previous CAR-T cell model to include CD4+ and CD8+ T cell lineages.
  • Incorporated CD4+-mediated modulation of CD8+ proliferation, cytotoxicity, and memory regeneration via saturating interactions.
  • Performed sensitivity analyses to identify key drivers of treatment outcome and conducted virtual patient simulations.
  • Introduced noise into model parameters to assess prediction limits and employed a feed-forward neural network to evaluate data-driven prediction capabilities.

Main Results:

  • Sensitivity analyses identified effector proliferation, antigen turnover, and CD8+ expansion rates as critical factors influencing CAR T-cell therapy outcomes.
  • Virtual patient simulations replicated known trends, demonstrating improved tumor clearance with defined CD4:CD8 ratios compared to CD8-only formulations.
  • Simulations also highlighted significant inter-patient variability and time-dependent effects in CAR T-cell dynamics.
  • A feed-forward neural network showed partial success in recovering predictive signal from noisy data, outperforming a baseline model.

Conclusions:

  • The extended mathematical model provides a framework for hypothesis generation regarding CAR T-cell dynamics and subset interactions.
  • Understanding the interplay between CD4+ and CD8+ T cells is crucial for optimizing CAR T-cell therapy efficacy.
  • Data-driven approaches can augment mechanistic modeling, particularly when parameter uncertainty limits predictive confidence in complex biological systems.